Neurotrophins and cytokines in neuronal plasticity

Novartis Foundation Symposium

Volumn 289, Issue , 2008, Pages 222-233

  Spedding, Michael ^a   Gressens, Pierre ^b  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKINE; NERVE GROWTH FACTOR;

ANIMAL; BIOLOGICAL MODEL; BRAIN; ENERGY METABOLISM; HUMAN; NERVE CELL PLASTICITY; PAIN; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SYNAPSE;

ANIMALS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CYTOKINES; ENERGY METABOLISM; HUMANS; MODELS, BIOLOGICAL; NERVE GROWTH FACTORS; NEURONAL PLASTICITY; PAIN; SYNAPSES;

EID: 48849090882     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (63)

1. Ackl N, Ising M, Schreiber YA, Atiya M, Sonntag A, Auer DP 2005 Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease. Neurosci Lett 384:23-28
2. Agid Y, Buzsaki G, Diamond DM et al 2007 How can drug discovery for psychiatric disorders be improved? Nat Rev Drug Discov 6:189-201
3. Bemelmans AP, Husson I, Jaquet M, Mallet J, Kosofsky BE, Gressens P 2006 Lentiviral-mediated gene transfer of brain-derived neurotrophic factor is neuroprotective in a mouse model of neonatal excitotoxic challenge. J Neurosci Res 83:50-60
4. Bhatt S, Siegel A 2006 Potentiating role of interleukin 2 (IL-2) receptors in the midbrain periaqueductal gray (PAG) upon defensive rage behavior in the cat: role of neurokinin NK(1) receptors. Behav Brain Res 167:251-260
5. Boillee S, Vande VC, Cleveland DW 2006a ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52:39-59
6. Boillee S, Yamanaka K, Lobsiger CS et al 2006b Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312:1389-1392
7. Buttigieg H, Kawaja MD, Fahnestock M 2007 Neurotrophic activity of proNGF in vivo. Exp Neurol 204:832-835
8. Cai Z, Lin S, Pang Y, Rhodes PG 2004 Brain injury induced by intracerebral injection of interleukin-1beta and tumor necrosis factor-alpha in the neonatal rat. Pediatr Res 56:377-384
9. Capsoni S, Cattaneo A 2006 On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer's disease. Cell Mol Neurobiol 26:619-633
10. Chen G, Manji HK 2006 The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers. Curr Opin Psychiatry 19:313-323
11. Dantzer R, Kelley KW 2007 Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 21:153-60
12. Dicou E, Rangon CM, Guimiot F, Spedding M, Gressens P 2003 Positive allosteric modulators of AMPA receptors are neuroprotective against lesions induced by an NMDA agonist in neonatal mouse brain. Brain Res 970:221-225
13. Dommergues MA, Patkai J, Renauld JC, Evrard P, Gressens P 2000 Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium. Ann Neurol 47:54-63
14. Duman CH, Duman RS 2005 Neurobiology and treatment of anxiety: signal transduction and neural plasticity. Handb Exp Pharmacol 305-334
15. Einat H, Yuan P, Manji HK 2005 Increased anxiety-like behaviors and mitochondrial dysfunction in mice with targeted mutation of the Bcl-2 gene: further support for the involvement of mitochondrial function in anxiety disorders. Behav Brain Res 165:172-180
16. Garzon DJ, Fahnestock M 2007 Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells. J Neurosci 27:2628-2635
17. Garzon D, Yu G, Fahnestock M 2002 A new brain-derived neurotrophic factor transcript and decrease in brain-derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer's disease parietal cortex. J Neurochem 82:1058-1064
18. Glazner GW, Mattson MP 2000 Differential effects of BDNF, ADNF9, and TNFalpha on levels of NMDA receptor subunits, calcium homeostasis, and neuronal vulnerability to excitotoxicity. Exp Neurol 161:442-452
19. Gluckman PD, Guan J, Williams C et al 1998 Asphyxial brain injury-the role of the IGF system. Mol Cell Endocrinol 140:95-99
20. Gressens P, Spedding M 2004 Strategies for neuroprotection in the newborn. Drug Discov Today Ther Strat 1:77-82
21. Gressens P, Spedding M, Gigler G et al 2005 The effects of AMPA receptor antagonists in models of stroke and neurodegeneration. Eur J Pharmacol 519:58-67
22. Han BH, Holtzman DM 2000 BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci 20:5775-5781
23. Hao Y, Creson T, Zhang L et al 2004 Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. J Neurosci 24:6590-6599
24. Hauser SL, Oksenberg JR 2006 The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 52:61-76
25. Hefti FF, Rosenthal A, Walicke PA et al 2006 Novel class of pain drugs based on antagonism of NGF. Trends Pharmacol Sci 27:85-91
26. Husson I, Rangon CM, Lelievre V et al 2005 BDNF-induced white matter neuroprotection and stage-dependent neuronal survival following a neonatal excitotoxic challenge. Cereb Cortex 15:250-261
27. Jay TM, Rocher C, Hotte M, Naudon L, Gurden H, Spedding M 2004 Plasticity at hippocampal to prefrontal cortex synapses is impaired by loss of dopamine and stress: importance for psychiatric diseases. Neurotox Res 6:233-244
28. Largeron M, Mesples B, Gressens P et al 2001 The neuroprotective activity of 8-alkylamino-1,4-benzoxazine antioxidants. Eur J Pharmacol 424:189-194
29. Lauterborn JC, Lynch G, Vanderklish P, Arai A, Gall CM 2000 Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons. J Neurosci 20:8-21
30. Lauterborn JC, Truong GS, Baudry M, Bi X, Lynch G, Gall CM 2003 Chronic elevation of brain-derived neurotrophic factor by ampakines. J Pharmacol Exp Ther 307:297-305
31. Leonoudakis D, Braithwaite SP, Beattie MS, Beattie EC 2004 TNFalpha-induced AMPA-receptor trafficking in CNS neurons; relevance to excitotoxicity? Neuron Glia Biol 1:263-273
32. Lever IJ, Bradbury EJ, Cunningham JR et al 2001 Brain-derived neurotrophic factor is released in the dorsal horn by distinctive patterns of afferent fiber stimulation. J Neurosci 21:4469-4477
33. Mackowiak M, O'Neill MJ, Hicks CA, Bleakman D, Skolnick P 2002 An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study. Neuropharmacology 43:1-10
34. Magarinos AM, Verdugo JM, McEwen BS 1997 Chronic stress alters synaptic terminal structure in hippocampus. Proc Natl Acad Sci USA 94:14002-14008
35. Manji HK, Drevets WC, Charney DS 2001 The cellular neurobiology of depression. Nat Med 7:541-547
36. Markham A, Cameron I, Franklin P, Spedding M 2004 BDNF increases rat brain mitochondrial respiratory coupling at complex I, but not complex II. Eur J Neurosci 20:1189-1196
37. Marret S, Mukendi R, Gadisseux JF, Gressens P, Evrard P 1995 Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic-like lesions. J Neuropathol Exp Neurol 54:358-370
38. Mayberg HS 1997 Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci 9:471-481
39. Mayberg HS, Lozano AM, Voon V et al 2005 Deep brain stimulation for treatment-resistant depression. Neuron 45:651-660
40. McEwen BS 2000 Effects of adverse experiences for brain structure and function. Biol Psychiatry 48:721-731
41. McEwen BS 2001 Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Ann N Y Acad Sci 933:265-277
42. McEwen BS, Magarinos AM 2001 Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders. Hum Psychopharmacol 16:S7-S19
43. McEwen BS, Olie JP 2005 Neurobiology of mood, anxiety, and emotions as revealed by studies of a unique antidepressant: tianeptine. Mol Psychiatry 10:525-537
44. Michael GJ, Averill S, Nitkunan A et al 1997 Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord. J Neurosci 17:8476-8490
45. Nagappan G, Lu B 2005 Activity-dependent modulation of the BDNF receptor TrkB: mechanisms and implications. Trends Neurosci 28:464-471
46. Ng YP, Cheung ZH, Ip NY 2006 STAT3 as a downstream mediator of Trk signaling and functions. J Biol Chem 281:15636-44
47. Pang PT, Teng HK, Zaitsev E et al 2004 Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 306:487-491
48. Pawlak R, Rao BS, Melchor JP, Chattarji S, McEwen B, Strickland S 2005 Tissue plasminogen activator and plasminogen mediate stress-induced decline of neuronal and cognitive functions in the mouse hippocampus. Proc Natl Acad Sci USA 102:18201-18206
49. Peng S, Wuu J, Mufson EJ, Fahnestock M 2005 Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J Neurochem 93:1412-1421
50. Pezet S, McMahon SB 2006 Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci 29:507-538
51. Plaisant F, Dommergues MA, Spedding M et al 2003 Neuroprotective properties of tianeptine: interactions with cytokines. Neuropharmacology 44:801-809
52. Reagan LP, Rosell DR, Wood GE et al 2004 Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: reversal by tianeptine. Proc Natl Acad Sci USA 101:2179-2184
53. Rex CS, Kramar EA, Colgin LL, Lin B, Gall CM, Lynch G 2005 Long-term potentiation is impaired in middle-aged rats: regional specificity and reversal by adenosine receptor antagonists. J Neurosci 25:5956-5966
54. Rocher C, Spedding M, Munoz C, Jay TM 2004 Acute stress-induced changes in hippocampal/ prefrontal circuits in rats: effects of antidepressants. Cereb Cortex 14:224-229
55. Sfaello I, Baud O, Arzimanoglou A, Gressens P 2005 Topiramate prevents excitotoxic damage in the newborn rodent brain. Neurobiol Dis 20:837-848
56. Slack SE, Grist J, Mac Q, McMahon SB, Pezet S 2005 TrkB expression and phospho-ERK activation by brain-derived neurotrophic factor in rat spinothalamic tract neurons. J Comp Neurol 489:59-68
57. Spedding M, Jay T, Costa e Silva J, Perret L 2005 A pathophysiological paradigm for the therapy of psychiatric disease. Nat Rev Drug Discov 4:467-476
58. Stellwagen D, Malenka RC 2006 Synaptic scaling mediated by glial TNF-alpha. Nature 440:1054-1059
59. Tahraoui SL, Marret S, Bodenant C et al 2001 Central role of microglia in neonatal excitotoxic lesions of the murine periventricular white matter. Brain Pathol 11:56-71
60. Ugolini G, Marinelli S, Covaceuszach S, Cattaneo A, Pavone F 2007 The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain. Proc Natl Acad Sci USA 104:2985-2990
61. Vyas A, Mitra R, Shankaranarayana Rao BS, Chattarji S 2002 Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci 22:6810-6818
62. Zalcman SS, Siegel A 2006 The neurobiology of aggression and rage: role of cytokines. Brain Behav Immun 20:507-514
63. Zhao J, Seereeram A, Nassar MA et al 2006 Nociceptor-derived brain-derived neurotrophic factor regulates acute and inflammatory but not neuropathic pain. Mol Cell Neurosci 31:539-548